Clinical Research Directory

Inclusion Criteria: * Clinical suspicion of prostate cancer (presence of elevated prostatic specific antigen and/or suspicious digital rectal examination); * Presence of at least one suspicious prostate lesion on MRI (Prostate Imaging-Reporting and Data System ≥ 3) according to the Prostate Imaging-Reporting and Data System v2.1 performed before Magnetic Resonance Imaging/transrectal ultrasound fusion biopsy. Exclusion Criteria: * Patients under active surveillance or with a previous diagnosis of prostate neoplasia prior to biopsy. * Previous radiotherapy to the prostate for neoplasia.